JP Morgan Upgrades Genpact to Neutral, Lowers Price Target to $40
$G
Professional Services
Consumer Discretionary
JP Morgan analyst Tien-Tsin Huang upgrades Genpact (NYSE:G) from Underweight to Neutral and lowers the price target from $43 to $40.
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/17/2024 | $43.00 → $40.00 | Underweight → Neutral | JP Morgan |
| 1/30/2024 | $40.00 | Neutral | Mizuho |
| 12/15/2023 | $38.00 | Outperform → Neutral | Robert W. Baird |
| 8/22/2023 | $40.00 | Neutral → Underweight | JP Morgan |
| 7/18/2023 | $46.00 → $42.00 | Buy → Neutral | Citigroup |
| 12/15/2022 | $55.00 → $50.00 | Overweight → Neutral | JP Morgan |
| 2/14/2022 | $57.00 → $51.00 | Outperform → Market Perform | Cowen & Co. |
| 1/26/2022 | $54.00 | Hold | Jefferies |
Strengthens Genpact's advanced technology offerings as an AWS Premier Tier Services Partner with full suite of AI, data and analytics, and machine learning AWS Competencies NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, announced it has achieved the Amazon Web Services (AWS) Generative AI Competency in Consulting Services. This recognition underscores Genpact's expertise in helping clients and AWS Partners implement generative artificial intelligence (AI) at scale. As an AWS Premier Tier Services Partner, Genpact offers advanced capabilities in data, analytics, and machine learning, positi
VANCOUVER, BC, Oct. 31, 2024 /CNW/ - Greenlane Renewables Inc. ("Greenlane") (TSX:GRN) (FSE: 52G) intends to announce its 2024 third quarter financial results on Thursday, November 7, 2024 after markets close, followed by a conference call at 5:00 PM ET (2:00 PM PT). Representing management will be Brad Douville, Chief Executive Officer, and Monty Balderston, Chief Financial Officer. A question and answer period with analysts will follow brief remarks from management. Live Conference CallThe public is invited to listen to the conference call in real time by telephone. To acce
Recognition highlights Genpact's innovative solution to reduce waste and improve efficiency NEW YORK, Oct. 31, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, has been honored with the Celonis "Best Use Case Ideation" award for its innovative sustainable supply chain solution for manufacturing clients. This recognition highlights Genpact's commitment to reducing waste and enhancing efficiency within manufacturing processes. Developed in partnership with Celonis, the global leader in process min
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
Seasoned technologist joins Genpact to accelerate AI and advanced technology roadmaps NEW YORK, Aug. 7, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that Sanjeev Vohra has been named as the Company's first Chief Technology & Innovation Officer, effective immediately. Vohra will report to President and CEO, Balkrishan "BK" Kalra. Vohra, a seasoned leader and respected innovator, brings more than 30 years of technology, consulting and industry expertise to Genpact. His appointm
NEW YORK, Aug. 5, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that Nicholas "Nick" Gangestad, Senior Vice President and Chief Financial Officer at Rockwell Automation, has been appointed to the Company's Board of Directors, effective August 12th, 2024. Gangestad will serve on the Board's Audit Committee. "Nick's deep expertise in finance and financial operations will not only provide additional insights to our Board, but will also give us valuable, first-hand perspectives on
Piyush Mehta, Genpact's Chief Human Resources Officer (CHRO) expands his role to Country Manager, India, reinforcing the company's ongoing commitment to innovation, growth, and talent in the region GURUGRAM, India, April 4, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, announced the expanded role of its CHRO, Piyush Mehta, to Country Manager, India, effective immediately. This move reflects Genpact's unwavering commitment to India and its pivot to an AI-first company. In 2023, Genpact opened
VANCOUVER, BC, Oct. 31, 2024 /CNW/ - Greenlane Renewables Inc. ("Greenlane") (TSX:GRN) (FSE: 52G) intends to announce its 2024 third quarter financial results on Thursday, November 7, 2024 after markets close, followed by a conference call at 5:00 PM ET (2:00 PM PT). Representing management will be Brad Douville, Chief Executive Officer, and Monty Balderston, Chief Financial Officer. A question and answer period with analysts will follow brief remarks from management. Live Conference CallThe public is invited to listen to the conference call in real time by telephone. To acce
NEW YORK, Oct. 17, 2024 /PRNewswire/ -- Genpact Limited (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that its board of directors has declared a cash dividend of $0.1525 per common share for the fourth quarter of 2024. The dividend is payable on December 23, 2024 to shareholders of record as of the close of business on December 9, 2024. The declaration of any future dividends will be at the discretion of the board of directors. About Genpact Genpact (NYSE:G) is a global professional services and solutions
NEW YORK, Oct. 10, 2024 /PRNewswire/ -- Genpact (NYSE:G) will report its financial results for the third quarter ended September 30, 2024 after the close of the U.S. financial markets on Thursday, November 7, 2024. Following the release, Genpact's management team will host a conference call at 5:00 p.m. ET to discuss the company's performance. Participants are encouraged to register in advance to receive a dial-in number and unique PIN for seamless access. While early log-in is recommended, registration and access will be available throughout the call. A live webcast will be a
10-Q - Genpact LTD (0001398659) (Filer)
8-K - Genpact LTD (0001398659) (Filer)
8-K - Genpact LTD (0001398659) (Filer)
Despite a market rebalancing away from large tech companies, reflected by an over 10% correction in the Roundhill Magnificent Seven ETF (NASDAQ:MAGS) in the past two weeks, the so-called “Magnificent Seven” companies still comprise an outsized portion of the S&P 500. The Data: The Magnificent 7 comprises seven of the largest U.S. technology companies weighted heavily in the SPDR S&P 500 ETF Trust (NYSE:SPY). Apple Inc (NASDAQ:AAPL), 6.93% of the index. Microsoft Corp (NASDAQ:MSFT), 6.66% of the index. NVIDIA Corp (NASDAQ:NVDA), 5.95% of the index. Alphabet Inc (NASDAQ:G) (NASDAQ:GOOGL), 4.45% of the index. Amazon.com Inc (NASDAQ:AMZN), 3.94% of the index. Meta Platforms
Ratings for Genpact (NYSE:G) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 4 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 3 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $37.2, a high estimate of $40.00, and a low estimate of $33.00. This current average has decreased by 3.63% from the previous aver
JP Morgan analyst Tien-Tsin Huang upgrades Genpact (NYSE:G) from Underweight to Neutral and lowers the price target from $43 to $40.
JP Morgan upgraded Genpact from Underweight to Neutral and set a new price target of $40.00 from $43.00 previously
Mizuho initiated coverage of Genpact with a rating of Neutral and set a new price target of $40.00
Robert W. Baird downgraded Genpact from Outperform to Neutral and set a new price target of $38.00